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Background: Because of methods required for obtaining isolated left 
ventricular myocytes, evaluation of the contractile function of isolated left 
ventricular myocytes in normal human patients has been limited. Accord- 
ingly, the goal of the present study was to develop a means to isolate human 
left ventricular myocytes from small myocardial biopsy specimens collected 
from patients undergoing elective coronary artery bypass operations and to 
characterize indices of myocyte contractile performance. Methods: Myocar- 
dial biopsy specimens were obtained from the anterior left ventricular f ee 
wall of 22 patients undergoing coronary artery bypass operations. Myocytes 
were isolated from these myocardial samples by means of a stepwise 
enzymatic digestion method and micro-trituration techniques. Isolated left 
ventricular myocyte contractile function was assessed by computer-assisted 
high-speed videomicroscopy under basal conditions and in response to 
/~-adrenergic receptor stimulation with isoproterenol. Results: A total of 804 
viable left ventricular myocytes were successfully examined from all of the 
myocardial biopsy specimens with an average of 37 - 4 myocytes per 
patient. All myocytes contracted homogeneously at a field stimulation of 1 
Hz with an average percent shortening of 3.7% + 0.1% and shortening 
velocity of 51.3 -+ 1.3 /tm/s. After/3-adrenergic receptor stimulation with 
isoproterenol, percent shortening and shortening velocity increased 149% 
and 118% above baseline, respectively (P < .05). Conclusion: The unique 
results of the present study demonstrated that a high yield of myocytes could 
be obtained from human left ventricular biopsy specimens taken during 
cardiac operations. These myocytes exhibited stable contractile performance 
and maintained the capacity to respond to an inotropic stimulus. The methods 
described herein provide a basis by which future studies could investigate 
intrinsic and extrinsic influences on left ventricular myocyte contractility in 
human beings. (J Thorac Cardiovasc Surg 1998;116:495-502) 
T he determinants of left ventricular (LV) pump function are preload, afterload, and intrinsic 
contractile state. Because of the interactions of 
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these determinants, a sessment of LV myocardial 
contractile performance in vivo can be problematic. 
Since the :fundamental contractile unit of the LV is 
the myocyte, a large number of studies have used 
isolated myocytes from various animal species to 
evaluate contractile function and excitation-contrac- 
tion processes. >s To obtain LV myocytes, the vast 
majority of these past studies used isolation tech- 
niques in which large portions of myocardium were 
digested through coronary perfusion of a collage- 
nase solution, t-~ In light of these coronary perfusion 
requirements, isolated human LV myocyte studies 
have been restricted to myopathic hearts exptanted 
at the time of transplantation or the uncommon 
situation of harvested hearts deemed unsuitable for 
transplantation. 7-1~ More recently, it has been sug- 
gested that human LV myocytes can be obtained 
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Fig 1. LV myocardial biopsy procedure including location of the biopsy site, excision of the specimen, and 
closure of the site with pledget-supported Prolene mattress utures. Ao, Aorta; PA, pulmonary artery; RV,, 
right ventricle; LV,, left ventricle. 
from small myocardial biopsy specimens. 12 Previous 
reports have used these human LV myocyte prepa- 
rations to examine cellular electrophysiology and 
calcium transients. 7'8' 11, 12 However, limited data 
exist with respect to contractile performance of 
human LV myocytcs. 9'lo, 13 Furthermore, to what 
extent the LV biopsy and isolation technique can be 
used in patients undergoing cardiac operations re- 
mains unclear. Accordingly, the goal of the present 
study was to characterize indices of isolated LV 
myocyte contractile performance in adults undergo- 
ing cardiac surgery. 
Methods 
In the present study, LV myocardial biopsy specimens 
were obtained from patients undergoing coronary artery 
bypass operations. Myocytes were isolated from these 
myocardial samples by means of a modification of a 
previously described method] 2Isolated LV myocyte con- 
tractile function was assessed by computer-assisted high- 
speed videomicroscopy TM under basal conditions and in 
response to inotropic stimulation with isoproterenol. 
Biopsy procedure. The study protocol was reviewed 
and approved by the Institutional Review Board of the 
Medical University of South Carolina before a W patient 
recruitment. Patients cheduled to undergo elective coro- 
nary artery bypass operations were selected for the study, 
and informed written consent was obtained. The mean 
patient age was 62 + 2 years with a range of 47 to 76 years. 
Preoperative LV function was assessed by ventriculogra- 
phy or echocardiography. These imaging modalities were 
used to confirm that no abnormal wall motion was present 
in the anterior LV region. LV ejection fraction was 55% 
_+ 2% with a range of 30% to 70%. After induction of 
general anesthesia with sufentanil and isoflurane, a me,- 
dian sternotomy was performed. During the time the 
heart was prepared for cardiopulmonary b pass, the an- 
terior LV was inspected for areas of infarction, fibrosis, or 
regional wall motion abnormalities. The region devoid of 
apparent epicardial vessels and fat along the distal left 
anterior descending coronary artery, triangulated by the 
LV apex and the last diagonal branch, was targeted for 
biopsy. With the use of a No. 11 scalpel, a snqall biopsy 
specimen (averaging 5 × 4 mm) was excised from the LV 
epicardial surface to a depth of approximately 3 mm. The 
specimen was immediately placed in an ice cold oxygen- 
ated transfer solution as described in the next section. The 
biopsy site was closed with pledger-supported 3-0 Prolene 
sutures (Ethicon, Inc., Somerville, NJ). An illustration of 
thc biopsy proccdure is provided in Fig 1. 
Myocyte isolation. The LV myocardial biopsy speci- 
mens were immediately placed in ice cold oxygenated 
HEPES-buffered balanced salt solution (pH 7.4) contain- 
ing the following: glucose, 10 retool/L; taurine, 20 
mmol/L; creatine, 5mmol/L; succinate, 5 retool/L; calcium 
(Ca ++) 2 /,mol/L; nitriloacetic acid, 5 mmol/L; and 
2,3-butanedione monoxime (BDM [Sigma Chemical 
Corp, St Louis, Mo]), 15 mmol/L. The specimens were 
transported to the laboratory within 30 minutes. While the 
specimens were maintained in solution, they were dis- 
sected free of any fatty tissue and finely minced. Speci- 
mens were then transferred to another oxygenated 
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HEPES solution containing Ca ++ (50 /xmol/L), protease 
(4 U/mL; Sigma Type XXIV, Sigma Chemical Corp), 
collagenase (400 U/mL; Worthington Biochemical Corp, 
Freehold, NJ), and BDM (15 mmol/L) and allowed to 
gently bubble in a water jacket at 35 ° C for 30 minutes. 
The myocytes were then resuspended in an oxygenated 
collagenase solution containing hyaluronidase (0.5 mg/ 
mL, Sigma Chemical Corp) and gently agitated for 90 
minutes at 35 ° C. The concentrations of enzymes (pro- 
tease, collagenase, and hyaluronidase) used in the isola- 
tio n procedure were based on previously published stud- 
ies, LT'la'13 as well as preliminary studies by this 
laboratory, to maximize cell yields. Myocytcs were then 
allowed to settle 3 to 5 minutes and form a pellet at room 
temperature. Thc supernatant was discarded and myo- 
cytes were resuspended in an oxygenated HEPES solution 
containing aerobic substrates, a 0.5 g/L concentration of 
bovine serum albumin (Sigma Chemical Corp) and a 300 
/xmol/L concentration of Ca ++. This last step was re- 
peated to wash out any remaining BDM. A large number 
of quiescent myocytes were routinely obtained (10%-50% 
yields) with yields often greater than 50%. BDM, which 
reversibly inhibits Ca' ' - induced force development by 
myofilamcnts, in addition to a zero or low Ca' ~ period, 
has been shown to produce higher cell yields by reducing 
cutting injury and hypcrcontracture injury early during the 
myocyte isolation process, as' 16 Myocytes were stored at 
room temperature in this final solution until used for 
contractility analysis. 
Myocyte contractility measurements. I olated myo- 
cytes were placed into a thermostatically controlled cham- 
ber containing an oxygenated Krebs balanced salt solution 
(pH 7.4) containing dextrose and Ca ++ (1 mmot/L) at 
37°C and imaged with an inverted microscope (World 
Precision Instruments, Sarasota, Fla). Individual myocytes 
were selected for analysis on the basis of a characteristic 
rod-shaped appearance with no membrane blebbing and 
quiescence in the presence of extracellular Ca ++ (l 
mmol/L). A homogeneous contractile response was elic- 
ited in each myocyte by field stimulation of the chamber at 
1 Hz ($11, Grass Instruments, Quincy, Mass) with a 5-ms 
pulse width and voltages 10% above contraction thresh- 
old. The polarity of the stimulating electrodes was alter- 
nated at every pulse to prevent buildup of electrochemical 
by-products.~4 Myocyte contractions were imaged with the 
use of a charge-coupled device with a non-interlaced scan 
rate of 240 Hz (GPCD60, Panasonic, Secaucus, NJ). In a 
past report from this laboratory, Fourier analysis of the 
myocyte contraction data revealed that 99% of the power 
spectrum component of the contractile signal was con- 
tained within 8 Hz. 14 Thus, according to the Nyquist 
sampling theorem, a sampling frequency of 16 Hz would 
be the minimum required to digitize the myocyte contrac- 
tile signal. Therefore the digitization sampling frequency 
of 240 Hz that was used in the present study was adequate 
to accurately characterize the myocyte contractile signal. 
Myocyte motion signals were captured with the cell par- 
allel to the video raster lines, and this video signal was 
input through an edge detector system (Crescent Elec- 
tronics, Sandy, Utah). The changes in light intensity at the 
myocyte dges were used to track myocyte motion. The 
distance between the left and right myocyte edges was 
converted into a voltage signal, digitized, and input into a 
computer (80486; Zeos International, Minneapolis, Minn) 
for subsequent analysis, as previously described. 17 Al- 
though myocyte contractility measurements were per- 
formed in this study within a 6-hour period, myocytes did 
remain viable for up to 24 hours after isolation. Baseline 
contraction profiles for each selected myocytc were re- 
corded fi-om a minimum of 20 consecutive contractions. 
After baseline measurements were recorded, a random 
subset of myocytes was exposed to the /3-adrcnergic 
receptor agonist isoproterenol. After a 3-minute xposure 
to isoproterenol, contractions were recorded. Parameters 
computed from the digitized contraction profiles of all 
myocytes included percent shortening, velocity of short- 
ening (micrometers per second), velocity of relengthening 
(micrometers per second), total contraction duration (mil- 
liseconds), and timc to peak contraction (milliseconds). 
All parameters were calculatcd for each contraction and 
thc results averaged for all contractions observed. 
Data analysis. MY0cytc function was analyzed patient 
to patient, with each patient being considered a separate 
block and the number of myocytes being considered 
repeated observations within each block. In addition, 
summary statistics were calculated in which all myocytes 
were combined for each patient. The myocyte contractile 
response to isoproterenol was compared to baseline val- 
ues by means of a paired t test. Myocyte contractile 
response to the different isoproterenol doses was com- 
pared by means of an unpaired t test. Linear and nonlin- 
ear regression analysis was performed to determine the 
relationship between LV ejection fraction and indices of 
LV myocyte contractile function. All statistical analysis 
was performed with the use of BMDP statistical software 
programs (BMDP Statistical Software, Inc, Los Angeles, 
Calif). Results are presented as mean _+ standard error of 
the mean unless otherwise indicated. 
Results 
Myocardial biopsy specimens were successfully 
collected from all 22 patients enrolled in the study. 
There were no complications related to the biopsy 
procedure. Of the study patients, 18% were taking 
angiotensin-converting enzyme inhibitors, 68% 
/3-adrenergic receptor antagonists, 36% calcium 
channel antagonists, 9% digoxin, and 18% diuretics. 
Viable LV myocytes were successfully obtained 
from all of the myocardial biopsy specimens and an 
average of 37 (standard deviation 20) individual 
myocytes were examined from each biopsy with a 
range of 5 to 71 myocytes. A phase-contrast pho- 
tomicrograph of a group of representative isolated 
LV myocytes and a representative contraction pro- 
file for a single myocyte are shown in Fig 2. The 
actual values for each myocyte broken down for 
each patient are illustrated in Fig 3. Also, the mean 
values for each patient for resting length, percent 
shortening, and shortening velocity are included. A 
distribution profile of individual myocyte resting 
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Fig 2. Top, Representative phase-contrast photomicrographs of LV myocytes obtained from a myocardial 
biopsy specimen viewed at low power (25×) and at high power (200×). After isolation, a high yield of 
viable myocytes maintained a characteristic rod-shaped appearance and were quiescent in extracellular 
calcium. Bottom, A representative digitized contraction profile of an individual LV myocyte xhibiting a 
homogeneous contraction response during field stimulation at 1 Hz. The digitized contraction profiles were 
analyzed for specific indices of contractile performance and are summarized in Table I. 
length for all myocytes examined is presented in Fig 
4. Summary data for isolated LV myocyte contrac= 
tile function for the total of 804 myocytes i shown in 
Table I. 
After baseline measurements of contractile func- 
tion, random subgroups of LV myocytes from each 
patient were exposed to either 12.5- or 25-nmol/L 
concentrations of isoproterenol. Consistent with 
/3-adrenergic receptor stimulation, myocyte contrac- 
tile function significantly increased from baseline 
values (all P < .001). The myocyte percent change 
from baseline after isoproterenol exposure for per- 
cent and velocity of shortening for each patient, as 
well as the overall means, are presented in Fig 5. In 
addition, myocyte relengthening velocity increased 
by 158.5% above baseline with a 12.5-nmol/L con- 
centration of isoproterenol and 189.1% with a 25- 
nmot/L concentration. Time to peak contraction 
increased 10.6% in the 12.5-nmol/L isoproterenol 
group and 22.3% with 25 nmol/L. Values for 
percent shortening and time to peak contraction 
were significantly higher in the 25 nmol/L-treated 
group versus the 12.5 nmol/L-treated group (P = 
.03 and .004, respectively). Thus the myocytes 
isolated from these LV myocardial biopsy speci- 
mens retained the capacity to respond to an 
inotropic stimulus. 
Linear and nonlinear egression analysis was per- 
formed to determine the relationship between LV 
ejection fraction a d indices of LV myocyte contrac- 
tile function. Linear regression coefficients (r 2) for 
LV ejection fraction relative to percent shortening 
and velocity of shortening were 0.035 and 0.024, 
respectively. Nonlinear, second-order coefficients 
(r a) for the same indices were 0.058 and 0.029. Thus 
there was no apparent relationship between any of 
the parameters of myocyte contractility and LV 
ejection fraction. 
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Fig. 3. Tile actual values of each LV myocyte for each patient are shown in the top graphs for resting 
length, percent shortening, and shortening velocity, respectively. The bottom graphs demonstrate the 
mean _+ standard error of the mean values of these indices calculated for the total number of myocytes 
studied for each patient. The summary data for all of the 1Wocytcs included in the study are found in Tablc i. 
Discussion 
Assessment of LV myocardial contractile perfor- 
mance in vivo can be problematic because of dy- 
namic interactions between preload, afterload, and 
neurohormonal system activational states. Accord- 
ingly, methods have been developed in which LV 
myocytes are isolated from various animal species 
through coronary perfusion techniques and exam- 
ined at the cellular level with respect to contractile 
processes and electrophysiologic events. ~-5 How- 
ever, because of the enzymatic digestive methods 
and amounts of myocardium required for these past 
studies, evaluation of isolated LV myocyte contrac- 
tile function in normal human beings has been 
limited. The goal of the present study was to develop 
a means to isolate human LV myocytes from small 
myocardial biopsy specimens collected from pa- 
tients undergoing elective coronary revasculariza- 
tion procedures and to characterize indices of myo- 
cyte contractile performance. The results of the 
present study demonstrated that a high yield of 
myocytes could be routinely obtained from human 
LV biopsy specimens that were calcium-tolerant, 
exhibited a homogeneous contraction profile, and 
maintained the capacity to respond to an inotropic 
stimulus. 
Recent studies have demonstrated that it is pos- 
sible to isolate myocytes from human myocardium. 
However, the majority of these studies used myo- 
cytes obtained from explanted hearts through per- 
fusion techniques. 7-1~ Moreover, the primary focus 
of these past studies had been to examine specific 
aspects of cellular electrophysiology, v' s, H More re- 
cently, Peeters and associates ~2 demonstrated the 
potential for obtaining viable human myocytes from 
myocardial biopsy specimens that have normal, sta- 
ble resting membrane potentials. However, it re- 
mained unclear whether contractile performance 
could be consistently measured in myocytes ob- 
tained from human LV myocardial biopsy speci- 
mens. Harding and colleagues 13 reported indices of 
contractile performance in human myocytes isolated 
by a variety of different methods. In this past report, 
the average number of myocytes studied flom bi- 
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Fig. 4. The distribution of individual myocyte resting 
lengths for all of the myocytes examined from the LV 
myocardial biopsy specimens. The mean resting length 
was 149 -+ 1 /xm. The resting lengths formed a Gaussian 
distribution as indicated by the solid line. 
opsy specimens was less than 2 myocytes per patient, 
while the present study examined an average of 37 
myocytes per patient. Moreover, in the past study by 
Harding and colleagues, t3 myocyte contractile func- 
tion was examined from patients in various tages of 
heart failure and under a number of different con- 
ditions. Thus the present study is the first to char- 
acterize myocyte contractile processes and/3-adren- 
ergic responsiveness in a large number of viable 
myocytes obtained from normal human LV myocar- 
dial biopsy specimens. 
Past animal studies have indicated that/3-adren- 
ergic receptor system activation increased isolated 
myocyte contractile function, a'5, t4, t8 Thus stimula- 
tion of the /3-adrenergic receptor system with iso- 
proterenol provides a means to measure the inotro.- 
pic capacity of the isolated myocyte. Studies of the 
/3-adrenergic receptor pathway in isolated human 
myocytes have primarily focused on examining elec- 
trophysiologic processes. ('' 7, 9 In the present study, 
isolated human myocyte contractile function was 
examined with the use of the/3-adrenergic re eptor 
agonist, isoproterenol, at concentrations that had 
been shown previously to produce a near maximal 
inotropic response in animal myocyte prepara- 
tions aT, as, 19 Use of this/3-adrenergic receptor ag - 
nist in the human LV myocyte preparation yielded a 
Table I. Isolated human LV  myocyte contractile 
function: Steady-state parameters 
Percent shortening (%) 
Shortening velocity (/xm/s) 
Relengthening velocity (/zm/s) 
Time to peak contraction (ms) 
Total contraction duration (ms) 
Number of myocytes 
3.66 + 0.08 
51.31 -+ 1.25 
48.82 + 1.46 
218.15 + 2.68 
533.43 + 6.64 
8O4 
Values presented as mean _+ standard error of the mean. 
robust response in contractile performance. Thus 
the results from this portion of the study demon- 
strated that myocytes obtained from myocardial 
biopsy specimens retained the capacity to respond 
to an inotropic stimulus. On the basis of the appar- 
ent dose-dependent response in the present study 
(25 nmol/L vs 12.5 nmol/L isoproterenol), future 
studies using this human isolated myocyte prepara- 
tion to compute dose-response curves for/3-adren- 
ergic receptor agonists would be warranted. 
The myocytes i olated in the present study were 
determined to be viable on the basis of several 
criteria as previously described. The concentrations 
of enzymes (protease, collagenase, and hyaluroni- 
dase) used in the isolation procedure were based on 
previously published studies, 1'7, s2, 13 as well as pre- 
liminary studies by this laboratory, to maximize cell 
yields. Past studies from this laboratory have dem- 
onstrated that collagenase digestion of isolated LV 
myocytes using appropriate buffering conditions re- 
sults in normal resting membrane potentials and no 
changes in myocyte action potential duration. 2° Fur- 
thermore, this laboratory has demonstrated previ- 
ously that collagenase digestion of ventricular myo- 
cytes does not alter calcium-mediated current or 
kinetics. 2° In the present study, collagenase-disasso- 
ciated myocytes responded to electrical stimulation 
and to receptor-mediated inotropic modulation. 
Taken together, these observations suggest that the 
isolated LV myocyte isolation procedure used 
herein is not associated with sarcolemmal injury or 
intrinsic alterations in Ca ++ homeostasis secondary 
to the isolation process. 
In the isolated myocyte contraction profiles, there 
appeared to be two phases to the relaxation process. 
These two phases likely reflect he active relaxation 
process (Ca ++ sequestration and cross-bridge re- 
lease) and passive relaxation caused by sustaining 
forces.21, 22 Future studies using this isolated system 
and specific compounds that modulate myocyte re- 
laxation will be necessary to more carefully identify 
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the determinants of the two phases of relaxation 
observed in the present study. 
In past studies in which dog and swine were used, 
isolated LV myocyte resting length was between 130 
and 150/xm 1' 3, 4, 5, 14, 17 and was very similar to the 
average human LV myocyte resting length observed 
in the present study (-150 /xm). The similarities 
between LV myocyte resting lengths observed in the 
present study and in large-animal studies suggest 
that resting length is conserved among mammalian 
species. Furthermore, the indices of isolated LV 
myocyte contractile function observed in the present 
study were also similar to those obtained from 
normal isolated dog and swine myocytes. 5' 14, 17, 18 
Specifically, isolated LV myocyte velocity of short- 
ening has been reported as 50 to 60/xm/s, consistent 
with the results of the present study (-50 /xm/s). 
Percent shortening, reported in healthy animals in 
the 3.5% to 5% range, is also consistent with the 
observations in the present study (-3.7%). 
Although in the present study a large number of 
viable myocytes were obtained from the myocardial 
biopsy specimens, there are several limitations that 
should be recognized. First, the myocytes examined 
in the present study were obtained from a specilic 
region of the anterior LV myocardium. Whether 
myocytes from this region exhibit contractile prop- 
erties representative of rnyocytes within the entire 
LV myocardium remains to be determined. Further- 
more, the LV myocardial biopsy specimens in the 
present study were obtained from patients with 
relatively preserved LV ejection fractions undergo- 
ing coronary artery bypass operations. Future stud- 
ies that examine indices of myocyte contractile 
performance in a wider spectrum of patients with 
different underlying cardiac disease states would be 
helpful. 
There are limitations of the in vitro system used in 
the present study, which prevent direct extrapola- 
tion to in vivo conditions. First, the isolated myocyte 
system provides optimal solute diffusion, which does 
not occur with intact myocardium. Second, this 
isolated myocyte system removes differences inbuff- 
ering capacity and extracellular influences that 
would be operative in pathologic onditions uch as 
hypertrophy and coronary artery disease. Past re- 
ports have demonstrated that changes in steady- 
state isolated myocyte contractile function directly 
reflect changes in the intrinsic LV contractile per- 
formance, as well as the capacity of the LV myocyte 
to function against agiven load. Is Using this isolated 
myocyte system, this laboratory has demonstrated 
that myocytes respond in a predictable manner to 
incrementally increased external oadY Thus, al- 
though the isolated myocyte function studies de- 
scribed in the present study were performed under 
equivalent unloaded conditions, it is likely that these 
findings can be translated into intrinsic myocardial 
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contract i le  capacity. The  outcomes  of the present  
study demonst ra ted  that  a high yield of  i so lated 
myocytes mainta in ing  a normal  inotropic  response  
capacity could be rel iably obta ined  f rom smal l  LV  
myocard ia l  b iopsy spec imens  taken f rom pat ients  
undergo ing  card iac  operat ions .  The  methods  de- 
scr ibed here in  prov ide  a basis by which future  
studies could invest igate intr insic and extrinsic influ- 
ences on LV  myocyte  contract i l i ty  in human beings. 
We express our appreciation to Jeffrey Mandel, Mark 
Clair, Stephen Krombach, Christopher Kerr, James McE1- 
murray, Terry Heslin, Laura Finklea, and Gregory Austin 
for technical assistance during the execution of this 
project. 
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